From: Together JUN and DDIT3 (CHOP) control retinal ganglion cell death after axonal injury
A. RGC per mm2 | ||||
 | WT | Ddit3 −/− | Jun −/− | Jun −/− Ddit3 −/− |
14 Day ONC | 976.4 ± 59.1 | 1625.4 ± 62.8 | 2954.5 ± 128.5 | 3053.9 ± 48.6 |
14 Day SHAM | 3306.8 ± 47.3 | 3191 ± 25.0 | 3178.5 ± 73.9 | 3060.6 ± 42.5 |
35 Day ONC | 681.4 ± 92.5 | 1484.8 ± 68.7 | 2340.5 ± 98.8 | 2729.8 ± 83.9 |
35 Day SHAM | 3149.4 ± 51.7 | 3125.8 ± 30.6 | 3103.5 ± 51.7 | 3085.4 ± 48.0 |
60 Day ONC | 427.2 ± 79.7 | 1041.4 ± 14.0 | 1635.9 ± 79.7 | 2577.4 ± 100.4 |
60 Day SHAM | 3166.7 ± 42.4 | 3122.9 ± 61.1 | 3006.3 ± 42.4 | 3108.2 ± 19.9 |
120 Day ONC | 219.0 ± 8.3 | 797.0 ± 40.1 | 1498.0 ± 88.3 | 2328.0 ± 179.4 |
120 Day SHAM | 3178.0 ± 30.1 | 3116.0 ± 52.4 | 3101.1 ± 38.9 | 3086.0 ± 61.1 |
B. % Survival (ONC/SHAM) | ||||
 | WT | Ddit3 −/− | Jun −/− | Jun −/− Ddit3 −/− |
14 Day | 29.5 ± 1.8 | 50.9 ± 0.6 | 93.0 ± 1.0 | 99.8 ± 0.3 |
35 Day | 21.6 ± 2.0 | 47.5 ± 2.2 | 75.4 ± 0.4 | 88.5 ± 1.3 |
60 Day | 13.5 ± 4.0 | 33.3 ± 3.2 | 54.4 ± 2.6 | 82.9 ± 2.8 |
120 Day | 6.9 ± 1.6 | 25.3 ± 2.7 | 48.3 ± 3.2 | 75.4 ± 5.8 |
C. One-way ANOVA followed by the Tukey’s post hoc test | ||||
               14 Days after ONC | ||||
 | WT | Ddit3 −/− | Jun −/− | |
Ddit3 −/− | <0.0001 | – | – | |
Jun −/− | <0.0001 | <0.0001 | – | |
Jun −/− Ddit3 −/− | <0.0001 | <0.0001 | 0.2107 | |
               35 Days after ONC | ||||
 | WT | Ddit3 −/− | Jun −/− | |
Ddit3 −/− | <0.0001 | – | – | |
Jun −/− | <0.0001 | <0.0001 | – | |
Jun −/− Ddit3 −/− | <0.0001 | <0.0001 | 0.0024 | |
               60 Days after ONC | ||||
 | WT | Ddit3 −/− | Jun −/− | |
Ddit3 −/− | <0.0001 | – | – | |
Jun −/− | <0.0001 | <0.0001 | – | |
Jun −/− Ddit3 −/− | <0.0001 | <0.0001 | <0.0001 | |
               120 Days after ONC | ||||
 | WT | Ddit3 −/− | Jun −/− | |
Ddit3 −/− | <0.0001 | – | – | |
Jun −/− | <0.0001 | <0.0001 | – | |
Jun −/− Ddit3 −/− | <0.0001 | <0.0001 | <0.0001 |